434
Views
21
CrossRef citations to date
0
Altmetric
Review

Psoriatic arthritis: lessons from imaging studies and implications for therapy

, , &
Pages 133-142 | Received 12 May 2016, Accepted 18 Jul 2016, Published online: 10 Aug 2016

References

  • Gladman DD, Antoni C, Mease P, et al. Psoriatic arthritis: epidemiology, clinical features, course and outcome. Ann Rheum Dis. 2005;64(Suppl II):14–17.
  • Haroon M, Gallagher P, Fitzgerald O. Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis. 2015;74:1045–1050.
  • Tillett W, Jadon D, Shaddick G, et al. Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritis. Ann Rheum Dis. 2013;72:1358–1361.
  • Moverley AR, Coates LC, Helliwell PS. Can biologic therapies be withdrawn or tapered in psoriatic arthritis? Clin Exp Rheumatol. 2013;31(Suppl 78):S51–S53.
  • Aleo E, Migone S, Prono V, et al. Imaging techniques in psoriatic arthritis: update 2012-2014 on current status and future prospects. J Rheumatol. 2015;93:53–56.
  • Coates LC, Hodgson R, Conaghan PG, et al. MRI and ultrasonography for diagnosis and monitoring of psoriatic arthritis. Best Pract Res Clin Rheumatol. 2012;26:805–822.
  • Filippucci E, Aydin SZ, Karadag O, et al. Reliability of high-resolution ultrasonography in the assessment of Achilles tendon enthesopathy in seronegative spondyloarthropathies. Ann Rheum Dis. 2009;68:1850–1855.
  • Gutierrez M, Filippucci E, De Angelis R, et al. A sonographic spectrum of psoriatic arthritis: “the five targets”. Clin Rheumatol. 2010;29:133–142.
  • Solivetti FM, Elia F, Teoli M, et al. Role of contrast enhanced ultrasound in early diagnosis of psoriatic arthritis. Dermatology. 2010;220:25–31.
  • Mathew AJ, Danda D, Conaghan PG. MRI and ultrasound in rheumatoid arthritis. Curr Opin Rheumatol. 2016;28:323–329.
  • Poggenborg RP, Sorensen IJ, Pedersen SJ, et al. Magnetic resonance imaging for diagnosing, monitoring and prognostication in psoriatic arthritis. Clin Exp Rheumatol. 2015;33(Suppl 93):S66–S69.
  • Weckbach S, Schewe S, Michaely HJ, et al. Whole-body MR imaging in psoriatic arthritis: additional value for therapeutic decision making. Eur J Radiol. 2011;77:149–155.
  • Poggenborg RP, Eshed I, Østergaard M, et al. Enthesitis in patients with psoriatic arthritis, axial spondyloarthritis and healthy subjects assessed by ‘head-to-toe’ whole body MRI and clinical examination. Ann Rheum Dis. 2015;74:823–829.
  • Mathew AJ, Bird P. Utility of in-office extremity magnetic resonance imaging in rheumatology. Indian J Rheumatol. 2015;10:140–146.
  • Cimmino MA, Barbieri F, Boesen M, et al. Dynamic contrast-enhanced magnetic resonance imaging of articular and extraarticular synovial structures of the hands in patients with psoriatic arthritis. J Rheumatol. 2012;89:44–48.
  • Hennigan S, Du J, Chung C, et al. Evaluation of enthesopathy in psoriatic arthritis using a 3-Tesla MRI and using novel ultrashort time echo (UTE) pulse sequences for imaging (abstract). Arthritis Rheum. 2007;56(Suppl F27):5.
  • Poggenborg RP, Pedersen SJ, Eshed I, et al. Head-to-toe whole-body MRI in psoriatic arthritis, axial spondyloarthritis and healthy subjects: first steps towards global inflammation and damage scores of peripheral and axial joints. Rheumatology. 2015;54:1039–1049.
  • McGonagle D, Ash Z, Dickie L, et al. The early phase of psoriatic arthritis. Ann Rheum Dis. 2011;70(Suppl 1):i71–i76.
  • McGonagle D, Tan AL, Møller Døhn U, et al. Microanatomic studies to define predictive factors for the topography of periarticular erosion formation in inflammatory arthritis. Arthritis Rheum. 2009;60:1042–1051.
  • Benjamin M, McGonagle D. Histopathologic changes at “synovio-entheseal complexes“ suggesting a novel mechanism for synovitis in osteoarthritis and spondylarthritis. Arthritis Rheum. 2007;56:3601–3609.
  • Gisondi P, Tinazzi I, El-Dalati G, et al. Lower limb enthesopathy in patients with psoriasis without clinical signs of arthropathy: a hospital-based case-control study. Ann Rheum Dis. 2008;67:26–30.
  • Gutierrez M, Filippucci E, De Angelis R, et al. Subclinical entheseal involvement in patients with psoriasis: an ultrasound study. Semin Arthritis Rheum. 2011;40:407–412.
  • De Filippis LG, Caliri A, Lo Gullo R, et al. Ultrasonography in the early diagnosis of psoriasis-associated enthesopathy. Int J Tissue React. 2005;27:159–162.
  • Ozçakar L, Cetin A, Inanici F, et al. Ultrasonographical evaluation of the Achilles’ tendon in psoriasis patients. Int J Dermatol. 2005;44:930–932.
  • Naredo E, Möller I, De Miguel E, et al. High prevalence of ultrasonographic synovitis and enthesopathy in patients with psoriasis without psoriatic arthritis: a prospective case-control study. Rheumatology. 2011;50:1838–1848.
  • Offidani A, Cellini A, Valeri G, et al. Subclinical joint involvement in psoriasis: magnetic resonance imaging and X-ray findings. Acta Derm Venerol. 1998;78:463–465.
  • Erdem CZ, Tekin NS, Sarikaya S, et al. MR imaging features of foot involvement in patients with psoriasis. Eur J Radiol. 2008;67:521–525.
  • Emad Y, Ragab Y, Gheita T, et al. Knee enthesitis and synovitis on magnetic resonance imaging in patients with psoriasis without arthritic symptoms. J Rheumatol. 2012;39:1979–1986.
  • Faustini F, Simon D, Oliveira I, et al. Subclinical joint inflammation in patients with psoriasis without concomitant psoriatic arthritis: a coss-sectional and longitudinal analysis. Ann Rheum Dis. 2016 Feb 25 [Epub ahead of print]. doi:10.1136/annrheumdis-2015-208821.
  • Bandinelli F, Denaro V, Prignano F, et al. Ultrasonographic wrist and hand abnormalities in early psoriatic arthritis patients: correlation with clinical, dermatological, serological and genetic indices. Clin Exp Rheumatol. 2015;33:330–335.
  • Freeston JE, Coates LC, Nam JL, et al. Is there subclinical synovitis in early psoriatic arthritis? A clinical comparison with gray-scale and power Doppler ultrasound. Arthritis Care Res. 2014;66:432–439.
  • Freeston JE, Coates LC, Helliwell PS, et al. Is there subclinical enthesitis in early psoriatic arthritis? A clinical comparison with power Doppler ultrasound. Arthritis Care Res. 2012;64:1617–1621.
  • Eder L, Jayakar J, Thavaneswaran A, et al. Is the Madrid sonographic enthesitis index useful for differentiating psoriatic arthritis from psoriasis alone and healthy controls? J Rheumatol. 2014;41:466–472.
  • Mandl P, Navarro-Compán V, Terslev L, et al. EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice. Ann Rheum Dis. 2015;74:1327–1339.
  • Fiocco U, Stramare R, Coran A, et al. Vascular perfusion kinetics by contrast-enhanced ultrasound are related to synovial microvascularity in the joints of psoriatic arthritis. Clin Rheumatol. 2015;34:1903–1912.
  • Ficjan A, Husic R, Gretler J, et al. Ultrasound composite scores for the assessment of inflammatory and structural pathologies in psoriatic arthritis (PsASon-Score). Arthritis Res Ther. 2014;16:476. doi:10.1186/s13075-014-0476-2.
  • Gutierrez M, Wortsman X, Filippucci E, et al. High-frequency sonography in the evaluation of psoriasis: nail and skin involvement. J Ultrasound Med. 2009;28:1569–1574.
  • Aydin SZ, Castillo-Gallego C, Ash ZR, et al. Ultrasonographic assessment of nail in psoriatic disease shows a link between onychopathy and distal interphalangeal joint extensor tendon enthesopathy. Dermatology. 2012;225:231–235.
  • Sandobal C, Carbó E, Iribas J, et al. Ultrasound nail imaging on patients with psoriasis and psoriatic arthritis compared with rheumatoid arthritis and control subjects. J Clin Rheumatol. 2014;20:21–24.
  • Gutierrez M, Filippucci E, Salaffi F, et al. Differential diagnosis between rheumatoid arthritis and psoriatic arthritis: the value of ultrasound findings at metacarpophalangeal joints level. Ann Rheum Dis. 2011;70:1111–1114.
  • Zabotti A, Salvin S, Quartuccio L, et al. Differentiation between early rheumatoid and early psoriatic arthritis by the ultrasonographic study of the synovio-entheseal complex of the small joints of hands. Clin Exp Rheumatol. 2016;34:459–465.
  • Tehranzadeh J, Ashikyan O, Anavim A, et al. Detailed analysis of contrast-enhanced MRI of hands and wrists in patients with psoriatic arthritis. Skeletal Radiol. 2008;37:433–442.
  • McGonagle D, Marzo-Ortega H, O’Connor P, et al. The role of biomechanical factors and HLA-B27 in magnetic resonance imaging – determined bone changes in plantar fascia enthesopathy. Arthritis Rheum. 2002;46:489–493.
  • Hodgson RJ, Menon N, Grainger AJ, et al. Quantitative MRI measurements of the Achilles tendon in spondyloarthritis using ultrashort echo times. Br J Radiol. 2012;85:e293–e299.
  • Poggenborg RP, Ostergaard M, Terslev L. Imaging in psoriatic arthritis. Rheum Dis Clin N Am. 2015;41:593–613.
  • Narváez J, Narváez JA, De Albert M, et al. Can magnetic resonance imaging of the hand and wrist differentiate between rheumatoid arthritis and psoriatic arthritis in the early stages of the disease? Semin Arthritis Rheum. 2012;42:234–245.
  • Mathew AJ, Panwar J, Francis I, et al. AB1041 office extremity magnetic resonance imaging (E-MRI) can differentiate psoriatic and rheumatoid arthritis without contrast enhancement. Ann Rheum Dis. 2015;74:1246–1247.
  • Braum LS, McGonagle D, Bruns A, et al. Characterisation of hand small joints arthropathy using high-resolution MRI- limited discrimination between osteoarthritis and psoriatic arthritis. Eur Radiol. 2013;23:1686–1693.
  • Soscia E, Sirignano C, Catalano O, et al. New developments in magnetic resonance imaging of the nail unit. J Rheumatol Suppl. 2012;89:49–53.
  • Soscia E, Scarpa R, Cimmino MA, et al. Magnetic resonance imaging of nail unit in psoriatic arthritis. J Rheumatol Suppl. 2009;83:42–45.
  • Aydin SZ, Ash ZR, Tinazzi I, et al. The link between enthesitis and arthritis in psoriatic arthritis: a switch to a vascular phenotype at insertions may play a role in arthritis development. Ann Rheum Dis. 2013;72:992–995.
  • El Miedany Y, El Gaafary M, Youssef S, et al. Tailored approach to early psoriatic arthritis patients: clinical and ultrasonographic predictors for structural joint damage. Clin Rheumatol. 2015;34:307–313.
  • Terslev L, Naredo E, Ignocco A, et al. Defining enthesitis in spondyloarthritis by ultrasound: results of a Delphi process and of a reliability reading exercise. Arthritis Care Res. 2014;5:741–748.
  • Tan YM, Ostergaard M, Doyle A, et al. MRI bone oedema scores are higher in the arthritis mutilans form of psoriatic arthritis and correlate with high radiographic scores for joint damage. Arthritis Res Ther. 2009;11:R2. doi:10.1186/ar2586.
  • Poggenborg RP, Wiell C, Bøyesen P, et al. No overall damage progression despite persistent inflammation in adalimumab treated psoriatic arthritis patients: results from an investigator-initiated 48-week comparative magnetic resonance imaging, computed tomography and radiography trial. Rheumatology. 2014;53:746–756.
  • D’Agostino M-A, Conaghan PG, Naredo E, et al. The OMERACT ultrasound task force – advances and priorities. J Rheumatol. 2009;36:1829–1832.
  • Wakefield RJ, Balint PV, Szkudlarek M, et al. Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol. 2005;32:2485–2487.
  • Fiocco U, Ferro F, Vezzù M, et al. Rheumatoid and psoriatic knee synovitis: clinical, grey scale and power Doppler ultrasound assessment of the response to etanercept. Ann Rheum Dis. 2005;64:899–905.
  • Bruyn GAW, Hanova P, Iagnocco A, et al. Ultrasound definition of tendon damage in patients with rheumatoid arthritis. Results of a OMERACT consensus-based ultrasound score focussing on the diagnostic reliability. Ann Rheum Dis. 2014;73:1929–1934.
  • Schäfer VS, Fleck M, Kellner H, et al. Evaluation of the novel ultrasound score for large joints in psoriatic arthritis and ankylosing spondylitis: six month experience in daily clinical practice. BMC Musculoskelet Disord. 2013;14:358.
  • Alcalde M, D’Agostino MA, Bruyn GAW, et al. A systemic literature review of US definitions, scoring systems and validity according to the OMERACT filter for tendon lesion in RA and other inflammatory joint diseases. Rheumatology. 2012;51:1261–1268.
  • Gutierrez M, Di Geso L, Salaffi F, et al. Development of a preliminary US power Doppler composite score for monitoring treatment in PsA. Rheumatology. 2012;51:1261–1268.
  • Iagnocco A, Naredo E, Wakefield R, et al. Responsiveness in rheumatoid arthritis. A report from the OMERACT 11 ultrasound workshop. J Rheumtol. 2014;41:379–382.
  • Balint PV, Kane D, Wilson H, et al. Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathy. Ann Rheum Dis. 2002;61:905–910.
  • De Miguel E, Cobo T, Muñoz-Fernández S, et al. Validity of enthesis ultrasound assessment in spondyloarthropathy. Ann Rheum Dis. 2009;68:169–174.
  • Brockbank JE, Stein M, Schentag CT, et al. Dactylitis in psoriatic arthritis: a marker for disease severity? Ann Rheum Dis. 2005;64:188–190.
  • Olivieri I, Barozzi L, Favaro L, et al. Dactylitis in patients with seronegative spondylarthropathy. Assessment by ultrasonography and magnetic resonance imaging. Arthritis Rheum. 1996;39:1524–1528.
  • Healy PJ, Groves C, Chandramohan M, et al. MRI changes in psoriatic dactylitis – extent of pathology, relationship to tenderness and correlation with clinical indices. Rheumatology. 2008;47:92–95.
  • Bakewell CJ, Olivieri I, Aydin SZ, et al. Ultrasound and magnetic resonance imaging in the evaluation of psoriatic dactylitis: status and perspectives. J Rheumatol. 2013;40:1951–1957.
  • Tan AL, Fukuba E, Halliday NA, et al. High-resolution MRI assessment of dactylitis in psoriatic arthritis shows flexor tendon pulley and sheath-related enthesitis. Ann Rheum Dis. 2015;74:185–189.
  • Chakr RM, Mendonca JA, Brenol CV, et al. Assessing rheumatoid arthritis disease activity with ultrasound. Clin Rheumatol. 2013;32:1249–1254.
  • Schirmer M, Duftner C, Schmidt WA, et al. Ultrasonography in inflammatory rheumatic disease: an overview. Nat Rev Rheumatol. 2011;7:479–488.
  • Husic R, Gretler J, Felber A, et al. Disparity between ultrasound and clinical findings in psoriatic arthritis. Ann Rheum Dis. 2014;73:1529–1536.
  • Michelsen B, Diamantopoulos AP, Hammer HB, et al. Ultrasonographic evaluation in psoriatic arthritis is a major importance in evaluating disease activity. Ann Rheum Dis. 2016 Apr 18 [Epub ahead of print]. doi:10.1136/annrheumdis-2015-208806.
  • D’Agostino MA, Said-Nahal R, Hacquard-Bouder C, et al. Assessment of peripheral enthesitis in the spondylarthropathies by ultrasonography combined with power Doppler: a cross-sectional study. Arthritis Rheum. 2003;48:523–533.
  • Ostergaard M, McQueen F, Wiell C, et al. The OMERACT psoriatic arthritis magnetic resonance imaging scoring system (PsAMRIS): definitions of key pathologies, suggested MRI sequences, and preliminary scoring system for PsA hands. J Rheumatol. 2009;36:1816–1824.
  • Boyesen P, McQueen FM, Gandjbakhch F, et al. The OMERACT psoriatic arthritis magnetic resonance imaging score (PsAMRIS) is reliable and sensitive to change: results from and OMERACT workshop. J Rheumatol. 2011;38:2034–2038.
  • Glinatsi D, Bird P, Gandjbakhch F, et al. Validation of the OMERACT psoriatic arthritis magnetic resonance imaging score (PsAMRIS) for the hand and foot in a randomized placebo-controlled trial. J Rheumatol. 2015;42:2473–2479.
  • Strube H, Becker-Gaab C, Saam T, et al. Feasibility and reproducibility of the PsAMRIS-H score for psoriatic arthritis in low-field strength dedicated extremity magnetic resonance imaging. Scan J Rheumatol. 2013;42:379–382.
  • Feletar M, Hall S, Bird P. Evaluation of magnetic resonance imaging responsiveness in active psoriatic arthritis at multiple timepoints during the first 12 weeks of antitumor necrosis factor therapy. J Rheumatol. 2016;43:75–80.
  • Yanaba K, Sadaoka A, Yonenaga T, et al. Adalimumab markedly improves enthesitis in patients with psoriatic arthritis: evaluation with a magnetic resonance imaging scoring system. J Dermatol. 2015;42:1153–1159.
  • Anandarajah AP, Ory P, Salonen D, et al. Effect of adalimumab on joint disease: features of patients with psoriatic arthritis detected by magnetic resonance imaging. Ann Reum Dis. 2010;69:206–209.
  • McQueen F, Lloyd R, Doyle A, et al. Zoledronic acid does not reduce MRI erosive progression in PsA but may suppress bone oedema: the Zoledronic Acid in Psoriatic Arthritis (ZAPA) study. Ann Rheum Dis. 2011;70:1091–1094.
  • Fiocco U, Sfriso P, Oliviero F, et al. Blockade of intra-articular TNF in peripheral spondyloarthritis: its relevance to clinical scores, quantitative imaging and synovial fluid and synovial tissue biomarkers. Joint Bone Spine. 2013;80:165–170.
  • Ostergaard M, Glinatsi D, Pedersen SJ, et al. Utility in clinical trials of magnetic resonance imaging for psoriatic arthritis: a report from the GRAPPA 2014 annual meeting. J Rheumatol. 2015;42:6. doi:10.3899/jrheum.150130.
  • Weill C, Szkudlarek M, Hasselquist M, et al. Ultrasonography, magnetic resonance imaging, radiography and clinical assessment of inflammatory and destructive changes in fingers and toes of patients with psoriatic arthritis. Arthritis Res Ther. 2007;9:R119.
  • Stone MA, White LM, Gladman DD, et al. Significance of clinical evaluation of the metacarpophalangeal joint in relation to synovial/bone pathology in rheumatoid and psoriatic arthritis detected by magnetic resonance imaging. J Rheumatol. 2009;36:2751–2757.
  • Coates LC, Fransen J, Helliwell PS. Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment. Ann Rheum Dis. 2010;69:48–53.
  • Coates LC, Helliwell PS. Validation of minimal disease activity criteria for psoriatic arthritis using interventional trial data. Arthritis Care Res. 2010;62:965–969.
  • Schoels MM, Aletaha D, Alasti F, et al. Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score. Ann Rheum Dis. 2016;75:811–818.
  • Coates LC, Helliwell PS. Defining low disease activity states in psoriatic arthritis using novel composite disease instruments. J Rheumatol. 2016;43:371–375.
  • Janta I, Martínez-Estupiñán L, Valor L, et al. Comparison between full and tapered dosages of biologic therapies in psoriatic arthritis patients: clinical and ultrasound assessment. Clin Rheumatol. 2015;34:935–942.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.